On the other hand, the upregulation of PIAS3 expression in various tumors can inhibit cell proliferation and increase drug chemosensitivities such as lung cancer, prostate cancer, and glioblastoma [49,50,51,52,53]. Here, PIAS3 is linked to prostate cancer.